Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-13

Clinical Trial Update: Leuprolide and Goserelin for Ovarian Function Suppression in Pre- or Peri-menopausal Women With Breast Cancer, OFS Trial [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating ovarian function suppression with leuprolide and goserelin in pre- or peri-menopausal women with breast cancer; the study is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Goserelin (Goserelin)
  • Leuprolide (Leuprolide acetate)

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | Phase 2 | Status: RECRUITING